Fees: Members - $300  /  Nonmembers - $400

Once you register you will be sent the links to complete the activities.

AGENDA   

Session # 1

Diabetes Population Health
Faculty:  Susan Millstein, MSW, MPH, Director, Diabetes Prevention and Control Program, NYS DOH
Objectives:
? Discuss the burden of diabetes and diabetes health disparities in New York State;
? Describe how a community pharmacist can help people with diabetes access diabetes self-management education;
? Identify three complications of poorly controlled diabetes.
0170-0000-20-049-L01-P / 1 CEU / Knowledge Based Activity / Initial Release Date 11/08/2020

Update on Diabetes: Medications, Clinical Guidelines and Treatment Recommendations
Faculty:  Michael P. Kane, PharmD, FCCP, BCPS, BCACP, Professor, Albany College of Pharmacy and Health S ciences, Clinical Pharmacy Specialist, Albany Medical Center Division of Community Endocrinology
Objectives:
? Compare the mechanism of action of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 (SGLT2) inhibitors, as well as their potential adverse effects;
? Explain current guideline treatment recommendations regarding GLP-1 RA and SGLT2 inhibition therapy for patients with type 2 diabetes;
? Discuss the role of these therapies regarding glycemic control, weight loss, ASCVD protection, renal protection, and heart failure protection in the Type 2 diabetes patient.
0170-0000-20-050-L01-P / 1.5 CEU / Application Based Activity / Initial Release Date 11/08/2020

The Targeted Patient: Identification, Referral and DSMES Care Plan Development 
Faculty:  John Croce, BSPharm, RPh, Owner, Four Corners Pharmacy; 2019 CPESN Luminary of the Year
Ryan Lindenau, PharmD, RPh, Clinical Pharmacist, Primary Care of Western NY; Director, UBSPPS / MFHC  PGY-1 Community-based Residency
Objectives:
? Describe the DSMES patient centered care process and how it applies to community pharmacy;
? Explain how DSMES supports decision-making, self-care behaviors, problem-solving and collaboration with the health care team to improve outcomes and quality of life;
? Discuss best practices for implementing a DSMES program in community pharmacy;
? Describe methods to document effective DSMES care plans to achieve patient clinical goals and accreditation requirements.
0170-0000-20-051-L01-P / 1.5 CEU / Knowledge Based Activity / Initial Release Date 11/08/2020
Closing Comments:   Christopher Daly, PharmD, MBA, BCACP, Network Facilitator, CPESN  Upstate NY and CPESN  Western NY

-   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -

Session # 2

The Path To Accreditation
Faculty:  Uzma Quraishi, MS, RDN; Managing Director, Education Recognition Program, American Diabetes Association
Sacha Uelman, RDN, CDE, Director of Diabetes Education and Prevention Programs; Association of  Diabetes Care and Education Specialists (ADCES)
Objectives:
  ? List the 2017 National Standards that may be used to structure DSMES program plans;
? Outline the ADCES Interpretive Guidance or ADA Review Criteria that may be applied to implement the national standards in a pharmacy practice setting;
? Identify the initial and annual requirements for ADCES Accreditation and ADA Recognition of DSMES services;
? Define the four critical times to refer to DSMES.
0170-0000-20-052-L01-P / 1.5 CEU / Knowledge Based Activity / Initial Release Date 11/08/2020

Building a Sustainable DSMES Practice Model:  Patients, Payors and Technology
Faculty:  Ashley Keller, CPhT, Partner Relationship Manager, OmniSYS
Objectives: 
? Identify strategies to engage patients outside of the pharmacy setting;
? Discuss Medicare enrollment steps and the Medicare reimbursement model;
? Describe payment models outside of Medicare;
? Explain the documentation and billing requirements for DSMES.
0170-0000-20-053-L01-P / 1 CEU / Knowledge Based Activity / Initial Release Date 11/08/2020

The Road to Practice Transformation:  Implementation of DSMES at the Pharmacy
Faculty:  Annie Rogers Eisenbeis, PharmD, Director of Practice Development, Missouri Pharmacy Assn.
Objectives:
? Discuss the advantages of a community pharmacy starting a DSMES practice site;
? Describe some best practice "pearls" of implementing a DSMES practice at a community pharmacy;
  ?   Explain the sustainable implications of establishing a DSMES practice at a community pharmacy.
01 70-0000-20-054-L04-P / 1.0 CEU / Knowledge Based Activity / Initial Release Date 11/08/2020  

Closing Comments:  Steven Moore, PharmD, RPh; PSSNY Chairman of the Board of Directors

-   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -

Total 7.5 Contact CPE Hours

$300 for members

$400 for non-members